Stock Information
Vertex Pharmaceuticals Inc (VRTX)
Ticker Symbol: VRTX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $126,211.81 mil
Piotroski score: 5
PE Ratio: 28.574
EPS (TTM): 15.3331
Revenue (TTM): $46.84 M
Dividend Yield: N/A%
ROE: 22.7%
Latest News
-
I Expect Crispr Therapeutics To Break Out As 2026 Revenue Exceeds Expectations
Tue, Mar 31, 2026 8:30 AM
-
If You Invested $1000 In Vertex Pharmaceuticals Stock 15 Years Ago, You Would Have This Much Today
Mon, Mar 30, 2026 5:30 PM
-
1 Cash-Producing Stock with Promising Prospects and 2 We Turn Down
Mon, Mar 30, 2026 6:38 AM
-
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Prime GARP Investment
Sat, Mar 28, 2026 1:11 PM
-
Wells Fargo Raises Vertex Pharmaceuticals (VRTX) Price Target to $550
Sat, Mar 28, 2026 7:17 AM
-
Jim Cramer on Corteva, Inc.: “I Would Continue to Own the Stock”
Fri, Mar 27, 2026 6:01 PM
-
Regeneron (REGN) and Sanofi Announce Dupixent Approval in Japan to Treat Bullous Pemphigoid
Fri, Mar 27, 2026 3:13 PM
-
Maze Therapeutics: MZE829 Presses Forward Despite Stock Price Drop
Fri, Mar 27, 2026 3:09 PM
-
Watching Vertex Pharmaceuticals; Shares Trading Lower, FDA Label Update For ALYFTREK Adds Neuropsychiatric Risk Warning And Intracranial Hypertension, Alongside Strengthened Liver Safety Monitoring
Fri, Mar 27, 2026 1:13 PM
-
2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds
Fri, Mar 27, 2026 8:26 AM
Key Financials
Financial data not available